Cardinal Health (CAH)
(Delayed Data from NYSE)
$100.66 USD
-0.01 (-0.01%)
Updated Aug 12, 2024 04:00 PM ET
After-Market: $100.64 -0.02 (-0.02%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth D Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$100.66 USD
-0.01 (-0.01%)
Updated Aug 12, 2024 04:00 PM ET
After-Market: $100.64 -0.02 (-0.02%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth D Momentum A VGM
Zacks News
Glaukos (GKOS) Q4 Earnings Miss Estimates, Revenues Rise Y/Y
by Zacks Equity Research
Glaukos' (GKOS) fourth-quarter revenues beat estimates as well as gained year over year. Gross margin improve, while higher operating expenses lead to a wider operating loss.
Tandem Diabetes (TNDM) Posts Wider Q4 Loss, Gross Margin Down
by Zacks Equity Research
Tandem Diabetes (TNDM) reports a higher-than-expected loss in the fourth quarter of 2023.
5 Stocks Favored by Brokers Amid the Current Uncertainty
by Maharathi Basu
We believe that stocks like Deutsche Bank (DB), Cross Country Healthcare (CCRN), Bread Financial (BFH), American Axle (AXL) and Cardinal Health (CAH) should be on an investor's watchlist.
Here's Why You Should Retain Align Technology (ALGN) Stock Now
by Zacks Equity Research
Investors are optimistic about Align Technology (ALGN) on continued geographic expansion.
Boston Scientific (BSX) Surges 4.6%: Will the Rally Continue?
by Zacks Equity Research
Boston Scientific (BSX) is benefitting from an impressive gain in MedSurg market share and the strong adoption of WATCHMAN FLX.
Charles River (CRL) Gains From CRADL Amid Soft Market Scenario
by Zacks Equity Research
Within DSA, Charles River (CRL) is currently the largest provider of outsourced drug discovery, non-clinical development and regulated safety testing services worldwide.
Sight Sciences (SGHT) to Expand in Europe With New Launch
by Zacks Equity Research
By tapping into the European market, Sight Sciences (SGHT) aims to capitalize on the growing demand for advanced eye care technologies.
Avanos (AVNS) Q4 Earnings Lag Estimates, Margins Contract
by Zacks Equity Research
Despite strength in Avanos' (AVNS) Digestive Health segment, its overall fourth-quarter results reflect soft performances.
Here's Why You Should Buy Zimmer Biomet (ZBH) Stock Now
by Zacks Equity Research
Strategic plans to drive the Knee business bode well for Zimmer Biomet (ZBH).
Globus Medical (GMED) Q4 Earnings Surpass, Margins Down
by Zacks Equity Research
Globus Medical's (GMED) fourth-quarter 2023 performance benefits from innovative launches across its product groups.
Medtronic (MDT) Q3 Earnings Beat Estimates, 2024 View Up
by Zacks Equity Research
Medtronic's (MDT) third-quarter organic growth reflects broad strength across businesses and geographies.
Here's Why Investors Should Retain ResMed (RMD) Stock for Now
by Zacks Equity Research
Investors are optimistic about ResMed's (RMD) increased adoption of AirSense10 and AirSense11 devices.
GE HealthCare's (GEHC) Tie-Up to Improve Care Accessibility
by Zacks Equity Research
GE HealthCare's (GEHC) latest alliance is likely to include investment in new technology systems, digital tools and resources, service and support across a variety of care areas.
Three Reasons to Retain Accuray (ARAY) Stock in Your Portfolio
by Zacks Equity Research
The continued solid demand for Accuray's (ARAY) products raises optimism about the stock.
Illumina (ILMN) Rides on NGS Portfolio Expansion Amid Macro Woe
by Zacks Equity Research
In reproductive health, Illumina (ILMN) primarily focuses on driving noninvasive prenatal testing (NIPT) adoption globally.
SenesTech (SNES) Expands in the Netherlands With Q-chem Deal
by Zacks Equity Research
SenesTech's (SNES) collaboration with Q-chem strategically aligns with the Netherlands' Integrated Pest Control program.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why You Should Retain Penumbra (PEN) Stock for Now
by Zacks Equity Research
Investors remain optimistic for Penumbra (PEN), backed by the strength of its portfolio.
Thermo Fisher (TMO) Introduces Dionex Inuvion IC system
by Zacks Equity Research
Thermo Fisher's (TMO) Dionex Inuvion system helps labs operate more effectively by providing simple, adjustable workflows and a small footprint.
Is Cardinal Health (CAH) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
QIAGEN (QGEN) Earns Notable Recognitions in Sustainability
by Zacks Equity Research
QIAGEN (QGEN) achieves the ACT Label for new eco-friendly QIAwave products and the first My Green Lab Platinum certification.
National Vision (EYE) Hurt by Business Closure, Macro Woe
by Zacks Equity Research
National Vision's (EYE) impending termination of the long-term partnership with Walmart is likely to significantly impact its business.
Is American Century U.S. Quality Value ETF (VALQ) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for VALQ
IDEXX (IDXX) Unveils Pet Owner Engagement Software Solution
by Zacks Equity Research
IDEXX's (IDXX) Vello software is an intuitive solution designed specifically for practice management software that enables practitioners to interact with pet owners before and after visits.
Integer Holdings (ITGR) Q4 Earnings and Sales Beat, Margins Up
by Zacks Equity Research
Integer Holdings (ITGR) reports fourth-quarter results, with earnings and revenues beating their respective consensus marks.